Increased cardiac sympathetic nerve activity in ovine heart failure is reduced by lesion of the area postrema, but not lamina terminalis

Abstract

Increased cardiac sympathetic nerve activity (CSNA) is a key feature of heart failure (HF) and is associated with poor outcome. There is evidence that central angiotensinergic mechanisms contribute to the increased CSNA in HF, but the central sites involved are unknown. In an ovine, rapid pacing model of HF, we investigated the contribution of the lamina terminalis and area postrema to the increased CSNA and also the responses to fourth ventricular infusion of the angiotensin type 1 receptor antagonist losartan. Ablation of the area postrema or sham lesion (n = 6/group), placement of lamina terminalis lesion electrodes (n = 5), and insertion of a cannula into the fourth ventricle (n = 6) were performed when ejection fraction was ~ 50%. When ejection fraction was < 40%, recording electrodes were implanted, and after 3 days, resting CSNA and baroreflex control of CSNA were measured before and following lesion of the lamina terminalis, in groups with lesion or sham lesion of the area postrema and before and following infusion of losartan (1.0 mg/h for 5 h) into the fourth ventricle. In conscious sheep with HF, lesion of the lamina terminalis did not significantly change CSNA (91 ± 2 vs. 86 ± 3 bursts/100 heart beats), whereas CSNA was reduced in the group with lesion of the area postrema (89 ± 3 to 45 ± 10 bursts/100 heart beats, P < 0.01) and following fourth ventricular infusion of losartan (89 ± 3 to 48 ± 8 bursts/100 heartbeats, P < 0.01). These findings indicate that the area postrema and brainstem angiotensinergic mechanisms may play an important role in determining the increased CSNA in HF.

Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury

“…The entire vascular system, from the heart to the smallest capillary, is lined by endothelial cells. A primary purpose of the microcirculation unit is to couple heart metabolic demand with glucose and oxygen delivery through the blood in a manner dependent on the endothelial-dependent vasodilation [191,192]. Of note, endothelial cells in the heart also adjust vascular resistance appropriately to systemic influences, such as blood gases, pH alterations, circulating hormones, blood pressure fluctuation, and shear stress [193,194].…”

Tanshinone IIA attenuates cardiac microvascular ischemia-reperfusion injury via regulating the SIRT1-PGC1α-mitochondrial apoptosis pathway

“…Although the incidence of acute myocardial infarction (AMI) has declined in recent years, AMI remains the leading cause of noncancer-related deaths worldwide (Abukar et al 2018;Ter Horst et al 2018). Timely reperfusion therapy via opening blocked coronary arteries is the standard treatment for patients with AMI.…”

Resveratrol attenuates cerebral ischaemia reperfusion injury via modulating mitochondrial dynamics homeostasis and activating AMPK‐Mfn1 pathway

“…Acute ischaemic stroke causes extensive death of neurons which increases the resultant disability and mortality significantly . Accordingly, timely reperfusion therapy is important as an effective approach to reverse the damage to brain function and thus improve the prognosis in patients with ischaemia stroke . However, reperfusion itself brings about additional damage to ischaemic brain tissue, and this is termed as ‘ischaemia reperfusion injury’ which accounts for increased perioperative mortality .…”